Drug
LY03005
LY03005 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
6
100%
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
6(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 16 (100.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_1
A Relative Bioavailability Food Effect Study of LY03005
NCT03822065
completedphase_1
A Study of LY03005 vs Pristiq
NCT03733574
completedphase_1
Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®
NCT03357796
completedphase_1
Pilot BA Study of New LY03005 vs Pristiq
NCT02988024
completedphase_1
Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005
NCT02271412
Clinical Trials (6)
Showing 6 of 6 trials
NCT03822065Phase 1
A Relative Bioavailability Food Effect Study of LY03005
NCT03733574Phase 1
A Study of LY03005 vs Pristiq
NCT03357796Phase 1
Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®
NCT02988024Phase 1
Pilot BA Study of New LY03005 vs Pristiq
NCT02271412Phase 1
Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005
NCT02055300Phase 1
Safety, Tolerability and Pharmacokinetics Study of LY03005
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6